Oncology in Clinical Trials

Therapeutic Areas


Description

Oncology is one of the most significant domains as far as Clinical Trial Projects are concerned. Clinical Trials in Oncology are somewhat more complicated than other therapeutic areas, with Clinical Endpoint and Adverse Event Reporting being some of the major differentiators. Therefore it becomes important for professionals working on Oncology trials to develop an understanding of the therapeutic area.
This short course aims at providing an overview of the Oncology Domain and the peculiarities of Clinical Trial projects in this therapeutic area. The course is designed and delivered by Dr Digant Gupta (https://www.linkedin.com/pub/digant-gupta/10/689/b49), a veteran in the subject with over 15 years of experience in Clinical Research.

The Modules covered are:
Introduction to Cancer
Cancer Risk Factors
Cancer Diagnosis and Staging
Basics of Cancer Treatment
Clinical Endpoints in Cancer
RECIST Guidelines

Pre-requisite:
Basic understanding of Clinical Trials
Work Experience of 1 year or more as Statistical Programmer in Clinical Trial Analytics (preferred)

[Important Note: If you are taking this course from India, please submit a short survey located at https://goo.gl/z2pCvB to receive the instructions for payment through NEFT. We regret the inconvenience caused and want to assure you that we shall soon make the online payment facility available for Indian audience. Participants from overseas locations will be able to pay using PayPal or Credit Card.]

Content
  • Section 1
  • Introduction
  • Introduction to the Faculty_New
  • Prologue_New
  • Course Overview
  • Section 2
  • 1. Introduction to Cancer_New
  • Section 3
  • 2. Cancer Risk Factors_New
  • Section 4
  • 3. Cancer Diagnosis and Staging_New
  • Section 5
  • 4. Basics of Cancer Treatment_new
  • Section 6
  • 5. Clinical Endpoints in Cancer_New
  • Section 7
  • 6. RECIST Guidelines_new
  • Section 8
  • Course Evaluation
Completion rules
  • All units must be completed
  • Leads to a certification with a duration: Forever